The American Brachytherapy Society (ABS) is pleased to announce the inaugural call for nominations for the 2025 Ulrich Henschke Award. This prestigious honor, named after Dr. Ulrich Henschke, the revered pioneer of modern brachytherapy, will be presented at our Annual Conference in Nashville, Tennessee. The award celebrates Dr. Henschke's groundbreaking work from the 1950s, which continues to influence our field today.
The Ulrich Henschke Award celebrates outstanding contributions to brachytherapy, notable achievements in the broader radiation therapy community, and dedicated service to ABS. This is a wonderful opportunity to recognize a peer who has significantly impacted our discipline through innovation, leadership, and commitment.
We encourage you to nominate practitioners who embody these qualities. Join us in recognizing those whose work inspires excellence in brachytherapy and furthers our mission.
For submission details, please click here. The deadline for nominations is March 31, 2025. All nominations will be considered and reviewed by the ABS Board of Directors, who will evaluate each candidate based on their contributions to the field, achievements in radiation therapy, and service to the ABS. The selected recipient will be notified by May 9th.
Thank you for considering this unique opportunity to highlight exceptional talent within our community. Together, we can continue to foster growth and recognition in the field of brachytherapy.
Past Henschke Award Recipients
The Ulrich Henschke Award is the highest honor that the American Brachytherapy Society can bestow on a practitioner of brachytherapy, awarded for contributions to the field of brachytherapy, the radiation therapy community, and to the ABS. Dr. Henschke is considered the father of modern-day brachytherapy for his initial work in the 1950s, including his technological advancements that are still in use today. The Board of Directors of the American Brachytherapy Society congratulates our past recipients. This is a significant designation bestowed by the ABS and is a tribute to the following recipients for their contributions and accomplishments in the field of brachytherapy.
| 2024 |
Brian J. Moran, MD, FABS |
| 2023 |
Steven J. Frank, MD, FABS |
| 2022 |
Akila N. Viswanathan, MD, FABS |
| 2021 | Mark Rivard, PhD, FAAPM, FABS Brown University |
| 2019 | Gregory Merrick, MD, FABS Urologic Research Institute, Ohio University School |
| 2018 | Robert R Kuske, MD, FACRO, FABS Arizona Breast Cancer Specialists |
| 2017 | Juanita M. Crook, MD, FRCPC, FABS BC Cancer Agency |
| 2016 | Jeffrey Demanes, MD, FACRO, FABS UCLA |
| 2015 | Bruce R. Thomadsen, PhD University of Wisconsin-Madison |
| 2014 | Beth A. Erickson, MD, FACR, FASTRO Medical College of Wisconsin |
| 2013 | Frank A. Vicini, MD, FACR Michigan Healthcare Professionals / 21st Century Oncology |
| 2011 | W. Robert Lee, MD, MS, M.Ed. Duke University |
| 2010 | Patricia J. Eifel, MD MD Anderson |
| 2009 | Michael Zelefsky, MD Memorial Sloan-Kettering Cancer Center |
| 2008 | Kent Wallner, MD Puget Sound Health Care System |
| 2007 | Subir Nag, MD, FACR, FACRO Kaiser Permanente Radiation Oncology |
| 2006 | Jeffrey Williamson, PhD Virginia Commonwealth University Radiation Oncology |
| 2005 | Alvaro Martinez, MD William Beaumont Hospital |
| 2003 | Louis B. Harrison, MD Beth Israel Medical Center |
| 2002 | John Blasko, M.D. Prostate Brachytherapy: Past, Present, and Future |
| 1999 | Luis Delclos, M.D. Irradiation for Malignant Tumors of the Vagina |
| 1995 | Colin Orton, Ph.D. The Dose-Rate Effect in Brachytherapy: Friend or Foe? |
| 1994 | Ravinder Nath, Ph.D. New Radionuclide Sources for Brachytherapy |
| 1993 | Alain Gerbaulet, M.D, Brachytherapy for Pediatric Malignancies |
| 1992 | Willet Whitmore, M.D. The Memorial Sloan Kettering Experience with 125-I for Prostrate Cancer: 1970-1985 |
| 1991 | Carlos Perez, M.D., FACR A Historic Perspective and Challenges in Brachytherapy of the Uterine Cervix |
| 1990 | Jack Fowler, D.Sc. The Role of Radiation Biology in Brachytherapy |
| 1989 | Professor Daniel Chassagne Results of Oral Cancer Brachytherapy |
| 1989 | J. Frank Wilson, M.D. Combined Modality Treatment with Brachytherapy |
| 1988 | Charles A.F. Joslin, M.D. High Activity Source Afterloading in Gynecological Cancer and Its Future Prospects |
| 1986 | Theodore L. Phillips, M.D. Neurobrachytherapy, State of the Art |
| 1985 | Samuel Hellman, M.D. Preservative Management of Breast Cancer |
| 1984 | Eric Hall, D.Sc. The Biological Basis of Endocurietherapy |
| 1984 | Bernard Pierquin, M.D. Account of French Fellows |
| 1982 | Lowell Anderson, Ph.D |
| 1981 | Basil Hilaris, M.D. |
| 1981 | A.M. Nisar Syed, M.D. Primary Irradiation on the Management of Cancer of the Breast |
